These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21806672)

  • 1. Oral finasteride improved the quality of life of androgenetic alopecia patients.
    Yamazaki M; Miyakura T; Uchiyama M; Hobo A; Irisawa R; Tsuboi R
    J Dermatol; 2011 Aug; 38(8):773-7. PubMed ID: 21806672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
    Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up.
    Rossi A; Cantisani C; Scarnò M; Trucchia A; Fortuna MC; Calvieri S
    Dermatol Ther; 2011; 24(4):455-61. PubMed ID: 21910805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finasteride induced depression: a prospective study.
    Rahimi-Ardabili B; Pourandarjani R; Habibollahi P; Mualeki A
    BMC Clin Pharmacol; 2006 Oct; 6():7. PubMed ID: 17026771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.
    Sato A; Takeda A
    J Dermatol; 2012 Jan; 39(1):27-32. PubMed ID: 21980923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
    Tanglertsampan C
    J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with finasteride and low-dose dutasteride in the treatment of androgenetic alopecia.
    Boyapati A; Sinclair R
    Australas J Dermatol; 2013 Feb; 54(1):49-51. PubMed ID: 22686691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
    Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
    Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finasteride treatment of female pattern hair loss.
    Iorizzo M; Vincenzi C; Voudouris S; Piraccini BM; Tosti A
    Arch Dermatol; 2006 Mar; 142(3):298-302. PubMed ID: 16549704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of sexual function with an international index of erectile function in subjects taking finasteride for androgenetic alopecia.
    Tosti A; Pazzaglia M; Soli M; Rossi A; Rebora A; Atzori L; Barbareschi M; Benci M; Voudouris S; Vena GA
    Arch Dermatol; 2004 Jul; 140(7):857-8. PubMed ID: 15262698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
    Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
    Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of modified DLQI-based questionnaires for evaluation of clinical efficacy of herbal medicine in chronic skin diseases.
    Kondoh A; Ohta Y; Yamamoto K; Iwashita K; Umezawa Y; Matsuyama T; Ozawa A; Shinohara Y
    Tokai J Exp Clin Med; 2005 Jul; 30(2):97-102. PubMed ID: 16146199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness-to-pay and quality of life in patients with vitiligo.
    Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
    Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
    Shanshanwal SJ; Dhurat RS
    Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
    Kaufman KD; Rotonda J; Shah AK; Meehan AG
    Eur J Dermatol; 2008; 18(4):400-6. PubMed ID: 18573712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia.
    Kang HW; Chae MH; Park SH; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Yoon TY; Kim WJ
    J Urol; 2017 Dec; 198(6):1340-1345. PubMed ID: 28743526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
    Finasteride Male Pattern Hair Loss Study Group
    Eur J Dermatol; 2002; 12(1):38-49. PubMed ID: 11809594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo.
    Olsen EA; Whiting DA; Savin R; Rodgers A; Johnson-Levonas AO; Round E; Rotonda J; Kaufman KD;
    J Am Acad Dermatol; 2012 Sep; 67(3):379-86. PubMed ID: 22325459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women.
    Trüeb RM;
    Dermatology; 2004; 209(3):202-7. PubMed ID: 15459533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.